Valneva SE Stock Nasdaq
Stocks
VALN
US92025Y1038
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
00:00:00 24/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.260 USD | -1.87% |
|
-6.24% | -40.36% |
| 10-08 | Valneva Says UK Revokes Chikungunya Virus Vaccine's Marketing Authorization; Shares Down Pre-Bell | MT |
| 10-08 | Valneva: United Kingdom Withdraws IXCHIQ Authorization |
| Market Cap | 441M 494M 408M 369M 691M 46.89B 702M 4.9B 1.94B 24.57B 1.85B 1.81B 77.46B | P/E 2026 * |
-5.34x | P/E 2027 * | 8.42x |
|---|---|---|---|---|---|
| Enterprise Value | 575M 644M 531M 481M 900M 61.11B 915M 6.39B 2.53B 32.02B 2.42B 2.36B 101B | EV / Sales 2026 * |
3.81x | EV / Sales 2027 * | 1.78x |
| Free-Float |
89.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VALN | Delayed | |
CBOE
| VALN | Real-time | |
Deutsche Boerse AG
| AYJ0 | Delayed | |
Börse Stuttgart
| AYJ0 | Delayed | |
Boerse Muenchen
| AYJ0 | Real-time |
Last Transcript: Valneva SE
| 1 day | -1.87% | ||
| 1 week | -6.24% | ||
| Current month | -14.96% | ||
| 1 month | -15.43% | ||
| 3 months | +10.04% | ||
| 6 months | -4.36% | ||
| Current year | -40.36% |
| 1 week | 5.25 | 5.84 | |
| 1 month | 5.25 | 6.49 | |
| Current year | 4.75 | 12.18 | |
| 1 year | 4.75 | 12.18 | |
| 3 years | 3.62 | 14.49 | |
| 5 years | 3.62 | 67.84 | |
| 10 years | 3.62 | 67.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 29/07/2021 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 20/12/2023 | |
James Sulat
BRD | Director/Board Member | 75 | 07/03/2013 |
| Chairman | 65 | 20/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.87% | -6.24% | - | - | 494M | ||
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | ||
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | ||
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | ||
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | ||
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | ||
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | ||
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | ||
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | ||
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | ||
| Average | +0.06% | +2.41% | +48.08% | +140.89% | 42.57B | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.02% | +142.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 151M 169M 139M 126M 237M 16.05B 240M 1.68B 665M 8.41B 635M 621M 26.52B | 283M 317M 262M 237M 444M 30.12B 451M 3.15B 1.25B 15.78B 1.19B 1.17B 49.76B |
| Net income | -81.11M -90.83M -74.93M -67.91M -127M -8.62B -129M -902M -357M -4.52B -341M -334M -14.24B | 53.07M 59.43M 49.03M 44.43M 83.12M 5.64B 84.5M 590M 234M 2.96B 223M 218M 9.32B |
| Net Debt | 134M 150M 124M 112M 209M 14.21B 213M 1.49B 589M 7.45B 562M 550M 23.48B | 62.48M 69.96M 57.72M 52.3M 97.85M 6.64B 99.47M 695M 275M 3.48B 263M 257M 10.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | $5.260 | -1.87% | 6,408 |
| 22/10/26 | $5.360 | -3.60% | 22,616 |
| 21/10/26 | $5.560 | -2.28% | 137,263 |
| 20/10/26 | $5.690 | +3.27% | 13,100 |
| 19/10/26 | $5.510 | -1.78% | 9,143 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- VALN Stock
Select your edition
All financial news and data tailored to specific country editions

















